Citation Impact

Citing Papers

Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
CpG island methylator phenotype in cancer
2004
Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
2011 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Genome-scale DNA methylation maps of pluripotent and differentiated cells
2008 StandoutNature
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
2002
Molecular imaging in drug development
2008 Standout
Functions of DNA methylation: islands, start sites, gene bodies and beyond
2012 Standout
Pancreatic cancer
2004 Standout
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
2006
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
CpG islands and the regulation of transcription
2011 Standout
The history of cancer epigenetics
2004 Standout
LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability
2007
DNA methylation patterns and epigenetic memory
2002 Standout
Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer
2007
Genomic instability and colon cancer
2003
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells
2006
Pancreatic cancer
2020 Standout
CpG island methylator phenotypes in aging and cancer
1999
Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis
2003
Cancer Metastasis: Building a Framework
2006 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer
2006
CpG methylation is maintained in human cancer cells lacking DNMT1
2000 Nature
Assessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
2002
Principles and challenges of genome-wide DNA methylation analysis
2010
The power and the promise of DNA methylation markers
2003
Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases
2003
Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS)
2002
Pancreatic cancer
2016 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Lung cancer: New biological insights and recent therapeutic advances
2011
An Sp1/Sp3 Binding Polymorphism Confers Methylation Protection
2008
Colorectal cancer
2013 Standout
The Epigenomics of Cancer
2007 Standout
A Genome-Wide Screen for Normally Methylated Human CpG Islands That Can Identify Novel Imprinted Genes
2002
CpG-Island Methylation in Aging and Cancer
2000
Epigenetics in Cancer
2008 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Pancreatic Adenocarcinoma
2014 Standout
Methylation matters
2001
Cancer genes and the pathways they control
2004 Standout
Tumour class prediction and discovery by microarray-based DNA methylation analysis
2002
The Mammalian Epigenome
2007 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Oesophageal carcinoma
2013 Standout
DNA methylation landscapes: provocative insights from epigenomics
2008 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
2001
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Evidence for an instructive mechanism of de novo methylation in cancer cells
2006
Gastric cancer
2020 Standout
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
2008
Microenvironmental regulation of metastasis
2008 Standout
Pancreatic Cancer
2010 Standout
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Epigenetic modifications and human disease
2010 Standout
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options
2007
The fundamental role of epigenetic events in cancer
2002 Standout
Pancreatic cancer
2011 Standout
Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters
2007
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
2007
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
DNA Methylation: A Profile of Methods and Applications
2002
Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53
2002
Accelerated age-related CpG island methylation in ulcerative colitis.
2001
A gene hypermethylation profile of human cancer.
2001 Standout
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
2005
Transcriptional control of human p53-regulated genes
2008 Standout
The serrated pathway to colorectal carcinoma: current concepts and challenges
2012
Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
2003
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
CpG island methylator phenotype in colorectal cancer
1999 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time.
2001

Works of Coty Ho being referenced

Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer
2006
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration
2006
Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer
2005
Phase Ia/Ib Chemo-Radiation Trial of Gemcitabine and Dose-Escalated Thoracic Radiation in Patients with Stage III A/B Non-small Cell Lung Cancer
2006
Phase la/lb Chemo-Radiation Trial of Gemcitabine and Dose-Escalated Thoracic Radiation in Patients with Stage III A/B Non-small Cell Lung Cancer
2006
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
1999
Rankless by CCL
2026